VANCOUVER, BRITISH COLUMBIA--(Marketwire - October 24, 2007) - Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) today announced that it has increased its revenue guidance to a range of CDN$8.75 to $9.25 million for fiscal 2007 based on the growth of contracted and forecasted tonnage for Reducol™, value added products and other sterol products for sale into the functional food and dietary supplement markets. The Company had previously issued revenue guidance of $7.5 to $8 million.
